MediciNova, Inc(NASDAQ:MNOV) 
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treati...
Website: http://medicinova.com
Founded: 2000
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.32
H 1.36
L 1.23
C 1.24
V 54,417
10EMA 1.24
20EMA 1.24
60EMA 1.24
120EMA 1.24
250EMA 1.24